US health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.

US drug maker Eli Lilly said it has paused its trial of a combination antibody treatment for COVID-19 for safety reasons.